- Home
- ETON vs NAAS Comparison
ETON vs NAAS Comparison
Compare ETON & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NAAS
- Stock Information
- Founded
- ETON 2017
- NAAS 2019
- Country
- ETON United States
- NAAS China
- Employees
- ETON N/A
- NAAS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- ETON Health Care
- NAAS Consumer Discretionary
- Exchange
- ETON Nasdaq
- NAAS Nasdaq
- Market Cap
- ETON 199.5M
- NAAS 54.6M
- IPO Year
- ETON 2018
- NAAS 2017
- Fundamental
- Price
- ETON $8.82
- NAAS $3.05
- Analyst Decision
- ETON Strong Buy
- NAAS
- Analyst Count
- ETON 3
- NAAS 0
- Target Price
- ETON $12.00
- NAAS N/A
- AVG Volume (30 Days)
- ETON 214.1K
- NAAS 179.6K
- Earning Date
- ETON 11-11-2024
- NAAS 11-05-2024
- Dividend Yield
- ETON N/A
- NAAS N/A
- EPS Growth
- ETON N/A
- NAAS N/A
- EPS
- ETON N/A
- NAAS N/A
- Revenue
- ETON $31,381,000.00
- NAAS $58,241,066.00
- Revenue This Year
- ETON $19.61
- NAAS $19.53
- Revenue Next Year
- ETON $35.39
- NAAS $151.36
- P/E Ratio
- ETON N/A
- NAAS N/A
- Revenue Growth
- ETON 8.14
- NAAS 199.95
- 52 Week Low
- ETON $3.03
- NAAS $1.42
- 52 Week High
- ETON $8.66
- NAAS $61.60
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- NAAS 42.32
- Support Level
- ETON $7.58
- NAAS $3.00
- Resistance Level
- ETON $8.66
- NAAS $3.35
- Average True Range (ATR)
- ETON 0.42
- NAAS 0.24
- MACD
- ETON -0.07
- NAAS -0.03
- Stochastic Oscillator
- ETON 91.49
- NAAS 20.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.